Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification
Formulation Information
SUPPOSITORY
**Dosage** One vaginal suppository in the evening, to be inserted deeply into the vagina, preferably while lying down. If symptoms persist, repeat with a second vaginal suppository seven days after the first insertion.
VAGINAL
Medical Information
**Indications** Local treatment of vaginal candidiasis
**Contraindications** Known hypersensitivity to any imidazole antimycotic or to any of the excipients. Concomitant use of contraceptive diaphragm.
G01AF
咪唑衍生物
Manufacturer Information
DCH AURIGA SINGAPORE
Trommsdorff GmbH & Co, KG
Active Ingredients
Documents
Patient Information Leaflets
ZVS 300mg - C2 - Consequential - PIL - Proposed Pristine.pdf
Approved: August 12, 2013